Parkman Healthcare Partners LLC Madrigal Pharmaceuticals, Inc. Transaction History

Parkman Healthcare Partners LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$231.06 - $307.08 $4.27 Million - $5.68 Million	18,499 Added 252.0%	25,840 $6.26 Million
Q4 2022 Feb 13, 2023	SELL	$58.39 - $296.54 $831,999 - $4.23 Million	-14,249 Reduced 66.0%	7,341 $2.13 Million
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $15,384 - $20,195	254 Added 1.19%	21,590 $1.4 Million
Q2 2022 Aug 12, 2022	BUY	$58.04 - $100.2 $64,192 - $110,821	1,106 Added 5.47%	21,336 $1.53 Million
Q1 2022 May 13, 2022	SELL	$55.89 - $101.89 $471,711 - $859,951	-8,440 Reduced 29.44%	20,230 $1.99 Million
Q4 2021 Feb 11, 2022	SELL	$72.34 - $95.09 $196,981 - $258,930	-2,723 Reduced 8.67%	28,670 $2.43 Million
Q3 2021 Nov 12, 2021	SELL	$78.35 - $105.02 $391,750 - $525,100	-5,000 Reduced 13.74%	31,393 $2.51 Million
Q2 2021 Aug 13, 2021	SELL	$97.2 - $137.59 $323,481 - $457,899	-3,328 Reduced 8.38%	36,393 $3.55 Million
Q1 2021 May 14, 2021	BUY	$108.54 - $125.2 $2.9 Million - $3.35 Million	26,745 Added 206.11%	39,721 $4.65 Million
Q4 2020 Feb 12, 2021	SELL	$110.06 - $133.7 $576,164 - $699,919	-5,235 Reduced 28.75%	12,976 $1.44 Million
Q3 2020 Nov 13, 2020	SELL	$99.78 - $124.21 $3.17 Million - $3.95 Million	-31,789 Reduced 63.58%	18,211 $2.16 Million
Q2 2020 Aug 13, 2020	BUY	$60.13 - $125.71 $1.2 Million - $2.51 Million	20,000 Added 66.67%	50,000 $5.66 Million
Q1 2020 May 15, 2020	BUY	$66.76 - $93.49 $2 Million - $2.8 Million	30,000 New	30,000 $2 Million

296

21.9M

819K

644K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.52B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.